JPMorgan Funds - Thematics - Genetic Therapies C (dist) - USD/ LU2309826514 /
| NAV10/06/2024 | Chg.-0.4400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 57.6600USD | -0.76% | paying dividend | Equity | JPMorgan AM (EU) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 11/06/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 01/03/2024 | Prospectus | 2024 | English | 12,571.47 KB |
| 01/03/2024 | Prospectus | 2024 | German | 13,030.79 KB |
| 01/01/2024 | Key Investor Information | 2024 | English | 79.72 KB |
| 31/12/2023 | Semi-annual report | 2023 | English | 2,988.31 KB |
| 31/12/2023 | Semi-annual report | 2023 | German | 3,041.32 KB |
| 06/12/2023 | PRIIP Key Information Document | 2023 | English | 97.05 KB |
| 06/12/2023 | PRIIP Key Information Document | 2023 | German | 101.87 KB |
| 30/06/2023 | Account statment | 2023 | English | 15,502.94 KB |
| 30/06/2023 | Account statment | 2023 | German | 13,816.29 KB |
| 08/11/2022 | Key Investor Information | 2022 | German | 81.69 KB |
